Haemophilia: open trials in France

26 open trials have a site in France. Registry data; only the trial team decides who can take part.

NCT07416604
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Trial Treatment · Phase 3 · Hoffmann-La Roche
Hospices Civils de Lyon, Bron · Bicetre Hospital, Le Kremlin Bicetre Cedex · Centre Hospitalier Universitaire de Lille, Lille · Assistance Publique Hopitaux de Paris, Paris
Registry updated 2026-11-03
NCT07830732
A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
Trial Treatment · Phase 3 · Novo Nordisk A/S
Hospices Civils de Lyon, Bron · Assistance Publique Hopitaux De Paris, Le Kremlin-Bicetre · Centre Hospitalier Universitaire de Lille, Lille · Centre Hospitalier Universitaire de Nantes, Nantes
Registry updated 2026-10-28
NCT05145127
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Trial Treatment · Phase 3 · Pfizer
Hopital Necker Enfants Malades, Paris
Registry updated 2026-10-26
NCT07416526
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Trial Treatment · Phase 3 · Hoffmann-La Roche
Hospices Civils de Lyon, Bron · Bicetre Hospital, Le Kremlin Bicetre Cedex · Centre Hospitalier Universitaire de Lille, Lille
Registry updated 2026-10-26
2025-523660-21-00
A Non-Investigational Product, Multi-Center Cohort Study to Describe Long-Term Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec
Trial Treatment · Phase 3 · Pfizer Inc.
Hospices Civils de Lyon - Hopital Louis Pradel, Bron · Hôpital Universitaire Necker Enfants Malades, Paris
Registry updated 2026-10-23
NCT06147414
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Research · Assistance Publique - Hôpitaux de Paris
Hôpital Cochin, Maternité Port-Royal, service de Gynécologie obstétrique, Paris
Registry updated 2026-10-21
NCT06379789
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
Trial Treatment · Phase 1/2 · Regeneron Pharmaceuticals
Hospices Civils de Lyon, Bron · Centre Hospitalier Universitaire de Lille, Lille · Assistance Publique Hopitaux de Paris, Paris
Registry updated 2026-10-21
NCT07080905
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
Trial Treatment · Phase 3 · CSL Behring
Centre Hospitalier Universitaire de Lille, Lille · Centre Hospitalier Regional De Marseille, Marseille
Registry updated 2026-10-20
NCT05611801
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Trial Treatment · Phase 3 · Pfizer
Hopital Necker Enfants Malades, Paris
Registry updated 2026-10-14
NCT07418827
Determinants and Consequences of the Transition to Adulthood for Adolescents With Severe Haemophilia: TRANSHEMO 2, an Ancillary Study to the TRANSHEMO Project
Research · Assistance Publique Hopitaux De Marseille
Ch Annecy - St Julien, Annecy · CHU de Bordeaux, Bordeaux · CHU de CAEN, Caen · Centre Hospitalier Métropole Savoie, Chambéry · CHU Clermont-Ferrand, Clermont-Ferrand · CHU de DIJON, Dijon · CHU de Grenoble, Grenoble · CHRU de Lille, Lille · CHU Limoges, Limoges · Hospices Civils de Lyon, Lyon · Assistance Publique Hôpitaux de Marseille, Marseille · CH Montmorency, Montmorency · CHU Montpellier, Montpellier · CHU de Nancy, Nancy · CHU Nantes, Nantes · AP-HP (Hôpital Kremlin Bicetre), Paris · AP-HP Hôpital Necker, Paris · CHU Reims, Reims · CHU de Rennes, Rennes · CHU de Rouen, Rouen · CHU La Réunion, Saint-Denis · Chu St-Etienne, Saint-Etienne · CHU Strasbourg, Strasbourg · CHU Toulouse, Toulouse · Ch Versailles, Versailles
Registry updated 2026-10-08
NCT05568719
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
Trial Treatment · Phase 3 · Pfizer
Hospices Civils de Lyon - Hopital Louis Pradel, Bron · Hôpital Universitaire Necker Enfants Malades, Paris
Registry updated 2026-10-07
NCT07830693
Efanesoctocog Prophylaxis Or The Optimization Of Treatment: Real-World Experience Of Taylorizing Clotting Therapy In Hemophilia A
Research · Nantes University Hospital
CHU Angers, Angers · CHU de Bordeaux - Hôpital Pellegrin, Bordeaux · Brest University Hospital, Brest · CHU de CAEN, Caen · CHRU de Tours - Hôpital Trousseau, Chambray-lès-Tours · CH Le Mans, Le Mans · CHU de Nantes, Nantes · Rennes University Hospital, Rennes
Registry updated 2026-09-25
NCT07220564
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Trial Treatment · Phase 1 · Novo Nordisk A/S
Hospices Civils de Lyon, Bron
Registry updated 2026-09-18
NCT07719647
Ultrasound Assessment of Joint Health in Patients With Mild Hemophilia (Factor Levels 5-40%)
Trial Treatment · Assistance Publique - Hôpitaux de Paris
Hopital Necker Enfants Malades, Paris
Registry updated 2026-08-17
NCT07723560
Study of Surgical Practices in Hemophilia A Patients Treated With Efanesoctocog Alfa (Altuvoct®)
Research · Hospices Civils de Lyon
Unité d'Hémostase Clinique Centre Régional de Traitement des Hémophiles Centre de Référence de Maladies Hémorragiques Hôpital Cardiologique Louis Pradel, Bron
Registry updated 2026-07-23
2022-502061-17-00
Nuwiq Dosing and outcomes In the ManagEment of women/girls with haemophilia A Needing FVIII treatment for Surgery – an International, Open-label, Non-controlled study (NuDIMENSION)
Trial Treatment · Phase 4 · Octapharma AG
Centre Hospitalier Universitaire de Nantes, Nantes · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2 · Centre Hospitalier Régional Universitaire de Tours, Tours
Registry updated 2026-07-10
NCT03695978
Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
Research · Octapharma
Centre Hospitalier Universitaire de Besançon, Besançon · The Centre Hospitalier Métropole Savoie, Chambéry · CHRU Tours - Hopital Trousseau, Chambray-lès-Tours · Centre Régional de Traitement de l'hémophilie, Le Mans · Hopital Simone Veil Groupement Hospitalier Eaubonne-Montmorency, Montmorency · CHU Hotel Dieu, Centre de Traitment de l'Hemophilie, Nantes · Hôspital Necker Enfants Malades, Paris · CHRU Hopital Nord, Secretariat de pediatre, bat E niv +3, Saint-Priest-en-Jarez
Registry updated 2026-06-02
NCT06090201
Severe Congenital Hemostatic Defects, Cerebral MIcrobleeds and COGnition
Research · University Hospital, Lille
CHU de Lille, Lille
Registry updated 2026-05-22
NCT05935358
Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Trial Treatment · Phase 4 · Octapharma
CHU de Nantes - Hôtel Dieu, Nantes · CHRU de Tours, Tours
Registry updated 2026-05-12
NCT05936580
Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
Trial Treatment · Phase 4 · Octapharma
Avenue de la République, Chambray-lès-Tours · CHU de Nantes - Hôtel Dieu, Nantes · Chu de Strasbourg, Stasbourg
Registry updated 2026-05-12
NCT07101926
Monitoring of Anti-TFPI in Hemophilia
Research · Hospices Civils de Lyon
Groupement hospitalier Est Hôpital Cardilogique Service d'hémostase clinique, Bron · Centre de Référence Hémophilie et autres déficits rares en protéine de la coagulationCentre de Traitemendes Hémophiles F. Josso, Paris
Registry updated 2026-03-23
NCT06008938
An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
Research · CSL Behring
Centre Hospitalier Universitaire de Brest / CHU Morvan, Brest · Centre Régional de Traitement de l'Hémophilie, Nantes · CHU Nancy - Hôpital Brabois, Vandœuvre-lès-Nancy
Registry updated 2026-02-19
NCT05768386
A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)
Research · Phase 4 · BioMarin Pharmaceutical
Centre Hospitalier Universitaire de Lille, Lille · Centre Hospitalier Regional De Marseille, Marseille
Registry updated 2026-01-12
NCT07314983
Long-term Anticoagulation in a Patient With Severe Hemophilia A
Research · University Hospital, Strasbourg, France
Laboratoire d'Hématologie - Unité d'Hémostase - CHU de Strasbourg - France, Strasbourg
Registry updated 2026-01-02
2022-502060-21-00
Nuwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis study (NuPOWER)
Trial Treatment · Phase 4 · Octapharma AG
Centre Hospitalier Universitaire de Nantes, Nantes · Centre Hospitalier Régional Universitaire de Tours, Tours
Registry updated 2025-09-25

All Haemophilia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error